SYLVANT 100 mg powder for concentrate for solution for infusion

Licence status
Authorised: 22/05/2014
Active substances
Siltuximab
Dosage Form
Powder for concentrate for solution for infusion
Licence number
EU/1/14/928/001
Licence holder
EUSA Pharma (Netherlands) B.V.

Product documents

Licence information

ATC code
L04AC Interleukin inhibitors, L04AC11 Interleukin inhibitors
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal products subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
22/05/2014